BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 27090216)

  • 1. The clinical results of proton beam therapy in patients with idiopathic pulmonary fibrosis: a single center experience.
    Ono T; Hareyama M; Nakamura T; Kimura K; Hayashi Y; Azami Y; Hirose K; Hatayama Y; Suzuki M; Wada H; Kikuchi Y; Nemoto K
    Radiat Oncol; 2016 Apr; 11():56. PubMed ID: 27090216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer.
    Ono T; Nakamura T; Yamaguchi H; Azami Y; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
    Radiat Oncol; 2018 Feb; 13(1):19. PubMed ID: 29402290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer.
    Gomez DR; Gillin M; Liao Z; Wei C; Lin SH; Swanick C; Alvarado T; Komaki R; Cox JD; Chang JY
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):665-70. PubMed ID: 23688815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection.
    Ono T; Nakamura T; Azami Y; Suzuki M; Wada H; Kikuchi Y; Murakami M; Nemoto K
    Thorac Cancer; 2019 Feb; 10(2):289-295. PubMed ID: 30585704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities.
    Parikh RR; Rhome R; Hug E; Tsai H; Cahlon O; Chon B; Goenka A
    Clin Lung Cancer; 2016 Sep; 17(5):362-366. PubMed ID: 27372386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
    Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
    Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verification of beam delivery using fibrosis after proton beam irradiation to the lung tumor.
    Fukumitsu N; Oshiro Y; Hashimoto T; Okumura T; Mizumoto M; Moritake T; Tsuboi K; Sakae T; Sakurai H
    Lung Cancer; 2012 Jul; 77(1):83-8. PubMed ID: 22281073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
    Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
    Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
    Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
    Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study.
    Morell F; Villar A; Montero MÁ; Muñoz X; Colby TV; Pipvath S; Cruz MJ; Raghu G
    Lancet Respir Med; 2013 Nov; 1(9):685-94. PubMed ID: 24429272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypofractionated proton beam therapy for centrally located lung cancer.
    Nakamura N; Hotta K; Zenda S; Baba H; Kito S; Akita T; Motegi A; Hojo H; Nakamura M; Parshuram RV; Okumura M; Akimoto T
    J Med Imaging Radiat Oncol; 2019 Aug; 63(4):552-556. PubMed ID: 31145553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
    Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy.
    Kim H; Pyo H; Noh JM; Lee W; Park B; Park HY; Yoo H
    Radiat Oncol; 2019 Jan; 14(1):19. PubMed ID: 30691496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
    Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose proton beam therapy for Stage I non-small-cell lung cancer.
    Nihei K; Ogino T; Ishikura S; Nishimura H
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):107-11. PubMed ID: 16458447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcome of intensity-modulated radiotherapy for inoperable non-small cell lung cancer: the MD Anderson experience.
    Jiang ZQ; Yang K; Komaki R; Wei X; Tucker SL; Zhuang Y; Martel MK; Vedam S; Balter P; Zhu G; Gomez D; Lu C; Mohan R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):332-9. PubMed ID: 22079735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiation pneumonitis and pulmonary fibrosis after the CT-planned radiotherapy of bronchial carcinoma].
    Müller G; Kiricuta IC; Stiess J; Bohndorf W
    Strahlenther Onkol; 1994 Jul; 170(7):400-7. PubMed ID: 8052939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.